"Then if it's similar to the only in vivo testing
Post# of 148158
(Total Views: 487)
Posted On: 02/08/2022 10:34:38 AM
"Then if it's similar to the only in vivo testing done how will the FDA view 42% efficacy?"
Based on recent history, it depends on who is making the decisions. At 42% efficacy, it should be well received, if either brain bleed or thrombosis are side effects.
Read More: https://investorshangout.com/post/view?id=633...z7KJj5ICZ3
Based on recent history, it depends on who is making the decisions. At 42% efficacy, it should be well received, if either brain bleed or thrombosis are side effects.
Read More: https://investorshangout.com/post/view?id=633...z7KJj5ICZ3
(3)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼